drugset / Trial / NCT01164761

Bioavailability Study of Ramipril 10 mg Capsules of Dr. Reddy's Laboratories Limited Under Fasting Conditions

NCT01164761

Phase 1 Completed 54 enrolled Dr. Reddy's Laboratories Limited
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is * To characterize the pharmacokinetic profile of the Ramipril 10 mg capsules relative to that of ALTACE@ 10 mg capsules in healthy, adult, human, male subjects under fasting conditions and to assess the bioequivalence. * To monitor the safety of the subjects.

Timeline

Start
2005-09
Primary completion
2005-09
Completion
2005-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Ramipril Small molecule 10 mg

Indications

No indication recorded.